Total Company Value: allakos.com (ALLK)
The market trend for Allakos Inc. (ALLK) shares on the GURU.Markets platform is recorded at . Allakos Inc. develops anti-inflammatory antibodies, relying on existing cash reserves until it generates revenue. Its success within the immunology ecosystem is driven by FDA verdicts and clinical trial results; meanwhile, demand for chronic disease therapies remains stable and is virtually immune to economic cycles.
Allakos (ALLK) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Allakos Inc. (ALLK)
The value of Allakos Inc. (ALLK) is determined as the sum of market capitalization and net debt, reflecting the actual cost of a full business buyout. By analyzing the enterprise value on this chart, an investor sees the actual scale of assets required to maintain costly R&D in immunology and protect its patent monopoly, confirming the company's financial stability in the face of regulatory barriers.
Competitor analysis for Allakos Inc.
argenx N.V. - Total Company Value|BNTX - Total Company Value|ABVX: Total Company Value|ADMA: Total Company Value|PTGX (protagonist-inc.com) - Enterprise Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|enGene Bio - Enterprise Value|RAPT: Enterprise Value|aerovatetx.com (JBIO) - Total Company Value|ACRS (aclaristx.com) - Total Company Value|Total Company Value Kyverna Therapeutics, Inc.|Total Company Value Tiziana Life Sciences Ltd.|Enterprise Value CABA|Enterprise Value VTYX (Ventyx Biosciences, Inc)|Total Company Value THTX (Theratechnologies Inc.)|avalotx.com - Enterprise Value|ELDN (Eledon Pharmaceuticals, Inc.) - Total Company Value|AGEN: Total Enterprise Value|Climb Bio, Inc. - Total Company Value|Company Buyout Price Zura Bio Ltd|ATYR - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Adagene Corp|IMA (ImageneBio Inc) - Enterprise Value|Company Buyout Price STTK (shattucklabs.com)|EQ - Total Company Value|Business Value Connect Biopharma Holdings CNTB|IMUX: Enterprise Value|Atara Biotherapeutics (ATRA) - Real Price to Acquire Entire Company|inflarx.de - Real Price to Acquire Entire Company|X4 Pharmaceuticals Inc. (XFOR) - Company Buyout Price|ACET (Adicet Bio Inc.) - Enterprise Value|Enterprise Value CELU|Total Company Value INmune Bio, Inc. (INMB)|Total Company Value BRNS (barinthusbio.com)|Total Company Value Kezar Life Sciences, Inc. KZR|SAB Biotherapeutics Inc. - Total Company Value|Akari Therapeutics plc - Total Company Value|ENLV: Enterprise Value|Total Company Value q32bio.com (QTTB)|geovax.com (GOVX) - Full Business Value|EDSA - Enterprise Value|Value Adjusted for Debt and Cash iBio Inc|Enterprise Value CARM|Enterprise Value XTLB (XTL Bio)|Total Company Value Bolt Biotherapeutics, Inc.|HCW Biologics, Inc. - Value Adjusted for Debt and Cash|APVO: Total Company Value|AIM - Real Price to Acquire Entire Company|ADTX: Enterprise Value|Enterprise Value GRI Bio Corporation|XRTX - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash reshapelifesciences.com|REVB (Revelation Biosciences, Inc.) - Enterprise Value|Company Buyout Price INDP (Indaptus Therapeutics Inc)|Scinai - Total Company Value|CalciMedica Inc - Real Price to Acquire Entire Company|AFMD: Total Company Value|HOOKIPA Pharma Inc. (HOOK) - Real Price to Acquire Entire Company|IGMS: Real Price to Acquire Entire Company|ITOS (iTeos Therapeutics Inc) - Enterprise Value|Total Company Value Ocean Bio (OCEA)|Business Value TC BioPharm Ltd|Third Harmonic Bio - Enterprise Value